Sign Up to like & get recommendations! 1
Published in 2017 at "Clinical Cardiology"
DOI: 10.1002/clc.22823
Abstract: In patients with acute pulmonary embolism (PE), detectable levels of cardiac troponin I (cTnI) using a highly sensitive assay have been associated with increased in‐hospital mortality. We sought to investigate the impact of detectable cTnI… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Clinical Cardiology"
DOI: 10.1002/clc.23786
Abstract: Accurate risk stratification is the most important step in the management of patients with acute pulmonary thromboembolism (PTE). Pulmonary embolism severity index (PESI) is a clinical tool for PTE risk stratification. CHA2DS2‐VASc score, a risk… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.22164
Abstract: Acute pulmonary embolism (PE) is a serious clinical disease characterized by a high mortality rate. The aim of this study was to assess the prognostic value of international normalized ratio (INR) in acute PE patients… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Pediatric Pulmonology"
DOI: 10.1002/ppul.24917
Abstract: Individuals with cystic fibrosis (CF) require higher dosages of aminoglycosides due to an increased volume of distribution (Vd) and clearance. Optimal dosing of aminoglycosides in the CF population is essential as repeated exposure to aminoglycosides… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Pediatric pulmonology"
DOI: 10.1002/ppul.25441
Abstract: Aminoglycosides are commonly used for the treatment of Pseudomonas aeruginosa (PsA) in the setting of acute pulmonary exacerbations (PEx) in pediatric patients with cystic fibrosis (CF). There are controversies and practice differences between institutions related… read more here.
Sign Up to like & get recommendations! 1
Published in 2023 at "Pulmonary Circulation"
DOI: 10.1002/pul2.12229
Abstract: Abstract There is paucity of data regarding the outcomes of hospitalized acute pulmonary embolism (PE) patients with heart failure (HF) and Coronavirus Disease 2019 (COVID‐19) infection. We utilized the 2020 National Inpatient Sample (NIS) Database… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Intensive Care Medicine"
DOI: 10.1007/s00134-022-06639-8
Abstract: Acute pulmonary oedema (APE) is one of the most common causes of unscheduled hospital admissions among patients 65 years old or older [1, 2], with up to half being critically ill [2]. APE is associated… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Journal of General Internal Medicine"
DOI: 10.1007/s11606-021-07289-0
Abstract: The management and outcomes of patients diagnosed with acute pulmonary embolism in primary care have not been characterized. To describe 30-day outcomes stratified by initial site-of-care decisions Multicenter retrospective cohort study Adults diagnosed with acute… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Internal and Emergency Medicine"
DOI: 10.1007/s11739-018-1805-2
Abstract: The prognostic assessment of patients with acute pulmonary embolism (PE) is essential to drive its management. The search for new prognostic factors is a central issue for a more accurate estimate of short-term adverse events.… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "General Thoracic and Cardiovascular Surgery"
DOI: 10.1007/s11748-019-01218-z
Abstract: Objectives Acute pulmonary thromboembolism is a fatal condition with high mortality rate in patients with hemodynamic collapse. Early diagnosis and aggressive treatment after circulatory collapse due to pulmonary thromboembolism are important. Although catheter-directed therapy or… read more here.
Sign Up to like & get recommendations! 1
Published in 2021 at "Current Treatment Options in Cardiovascular Medicine"
DOI: 10.1007/s11936-021-00920-7
Abstract: Acute pulmonary embolism (PE) remains an important cause of cardiovascular mortality and morbidity in the USA and worldwide. Catheter-based therapies are emerging as a new armamentarium for improving outcomes in these patients. The purpose of… read more here.